Brazil Point-of-care Molecular Diagnostics Market Size & Outlook
Brazil point-of-care molecular diagnostics market, 2018-2030 (US$M)
Related Markets
Brazil point-of-care molecular diagnostics market highlights
- The Brazil point-of-care molecular diagnostics market generated a revenue of USD 88.0 million in 2023 and is expected to reach USD 115.0 million by 2030.
- The Brazil market is expected to grow at a CAGR of 3.9% from 2024 to 2030.
- In terms of segment, infectious diseases was the largest revenue generating application in 2023.
- Oncology is the most lucrative application segment registering the fastest growth during the forecast period.
Point-of-care molecular diagnostics market data book summary
| Market revenue in 2023 | USD 88.0 million |
| Market revenue in 2030 | USD 115.0 million |
| Growth rate | 3.9% (CAGR from 2023 to 2030) |
| Largest segment | Infectious diseases |
| Fastest growing segment | Oncology |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oncology, Prenatal Testing, Endocrinology, Other Applications, Hematology, Infectious Diseases |
| Key market players worldwide | Roche, Abbott Laboratories, Qiagen NV, Bayer AG, Nova Biomedical, Danaher Corp, Nipro Corp, Bio-Rad Laboratories Inc, Agilent Technologies Inc, BioMerieux SA, OraSure Technologies Inc, Abaxis |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.7% of the global point-of-care molecular diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil point-of-care molecular diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 115.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Point-of-Care Molecular Diagnostics Market Scope
Point-of-Care Molecular Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil point-of-care molecular diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care molecular diagnostics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 93.41% in 2023. Horizon Databook has segmented the Brazil point-of-care molecular diagnostics market based on oncology, prenatal testing, endocrinology, other applications, hematology, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil is the fifth-largest country in the world and the most developed in Latin America. It is a potential market for POC diagnostic products. The rising incidence of disease tests related to antenatal syphilis screening, Human Immunodeficiency Virus (HIV) screening, coronavirus, and Zika virus are anticipated to have a positive impact on market growth over the forecast period.
Healthcare reforms, such as the Unified Health System (SUS) in Brazil, are estimated to boost the usage rates of PoC devices. In October 2015, PAHO/WHO was notified by the National IHR Focal Point of Brazil about the need for emergency preparedness in response to cases of Zika virus infections, which were found to be increasing in Brazil & Colombia.
Moreover, as reported in April 2020, the United Nations Global Compact in Brazil engaged in the collection of information on measures that companies are adopting to overcome the COVID-19 pandemic. Similarly, the Indiana State Department of Health is providing drivethru COVID-19 testing facilities in Brazil. Such initiatives are expected to boost the testing of infectious diseases in this region, consequently creating opportunities for POC tests.
Reasons to subscribe to Brazil point-of-care molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil point-of-care molecular diagnostics market databook
-
Our clientele includes a mix of point-of-care molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil point-of-care molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil point-of-care molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil point-of-care molecular diagnostics market size, by application, 2018-2030 (US$M)
Brazil Point-of-Care Molecular Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
